MARKET

BMRA

BMRA

Biomerica Inc
NASDAQ
3.040
+0.010
+0.33%
After Hours: 3.020 -0.02 -0.66% 16:04 07/15 EDT
OPEN
3.050
PREV CLOSE
3.030
HIGH
3.100
LOW
2.940
VOLUME
115.55K
TURNOVER
--
52 WEEK HIGH
10.16
52 WEEK LOW
1.932
MARKET CAP
7.74M
P/E (TTM)
-1.3629
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at BMRA last week (0707-0711)?
Weekly Report · 2d ago
Reported Earlier: Biomerica Has Been Granted Canadian Patent Number 3145879 Titled "COMPOSITIONS, DEVICES, AND METHODS OF IBS SENSITIVITY TESTING".
Benzinga · 5d ago
Weekly Report: what happened at BMRA last week (0630-0704)?
Weekly Report · 07/07 11:46
Biomerica Secures PLA Code For InFoods IBS Test, Advancing Reimbursement Access
NASDAQ · 07/02 18:29
Biomerica announces inFoods IBS received CPT PLA code
TipRanks · 07/02 12:16
Biomerica's inFoods IBS Test Receives AMA PLA Code, Advancing Path To Insurance Reimbursement And Wider Patient Access
Benzinga · 07/02 12:09
InFoods IBS receives CPT® Proprietary Laboratory Analysis (PLA) Code
Barchart · 07/02 07:08
Weekly Report: what happened at BMRA last week (0623-0627)?
Weekly Report · 06/30 11:54
More
About BMRA
Biomerica, Inc. is a biomedical technology company that develops, patents, manufactures and markets advanced diagnostic and therapeutic products. Its diagnostic test kits are utilized in the analysis of blood, urine, nasal, or fecal samples for the diagnosis of various diseases, food intolerances, and other medical conditions. Its range of medical diagnostic products is sold primarily in two markets: clinical laboratories and point-of-care settings, including physicians’ offices and over-the-counter sales. It is focused on research and development efforts and is its patented diagnostic-guided therapy (DGT) product, developed on the in Foods technology platform. Its inFoods IBS product, uses a simple blood test to identify patient-specific foods that, when eliminated, may alleviate IBS symptoms such as pain, bloating, diarrhea, cramping, and constipation. Its hp+detect, a new diagnostic test for detecting Helicobacter pylori (H. pylori) bacteria in the gastrointestinal tract.

Webull offers Biomerica Inc stock information, including NASDAQ: BMRA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BMRA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BMRA stock methods without spending real money on the virtual paper trading platform.